AYTU BIOPHARMA, INC Annual Net Cash Provided by (Used in) Financing Activities in USD from 2011 to 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
-
Summary
-
Aytu Biopharma, Inc annual/quarterly Net Cash Provided by (Used in) Financing Activities history and growth rate from 2011 to 2024.
- Aytu Biopharma, Inc Net Cash Provided by (Used in) Financing Activities for the quarter ending September 30, 2023 was -$2.73M, a 120% decline year-over-year.
- Aytu Biopharma, Inc annual Net Cash Provided by (Used in) Financing Activities for 2024 was -$1.26M, a 114% decline from 2023.
- Aytu Biopharma, Inc annual Net Cash Provided by (Used in) Financing Activities for 2023 was $8.87M, a 480% increase from 2022.
- Aytu Biopharma, Inc annual Net Cash Provided by (Used in) Financing Activities for 2022 was $1.53M, a 95% decline from 2021.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)